Respiratory viral infections and allergic rhinitis are common indications requiring well-tolerated local solutions suitable for repeated use.
Conventional pharmacological treatments may present limitations for prolonged use, particularly in children and sensitive populations.
In this context, mechanically acting medical devices provide a complementary approach allowing early and repeated use.
A carrageenan-based formulation enables:
Nasal spray containing Carragelose® intended for prophylaxis and supportive treatment of viral infections of the upper respiratory tract.
Objective: provide local non-pharmacological protection suitable for repeated use
Key characteristics
✓
Local mechanical action
Formation of a physical barrier on the nasal mucosa.
✓
Tolerance
Compatible with repeated intranasal use.
✓
Broad target population
Suitable for both children and adults. More than 1,000 patients included in international clinical trials.
✓
Therapeutic positioning
Complementary approach to symptomatic treatments.
| Spray | Volume | Category | Status | Dossier | Country |
|---|---|---|---|---|---|
| Carragelose - Nasal spray for colds for children over one year old, 1.2 mg/ml | 20 ml | Cough and Cold | MD (IIa) | CE marking in transition N | Contact us |
| Carragelose - Throat spray for adults and children from 1 year old, 1.2 mg/ml | 20 ml | Cough and Cold | MD (IIa) | CE marking in transition N | Contact us |
